Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNA polymerase-associated protein RTF1 homolog (RTF1) is a pivotal transcription elongation factor and subunit of the PAF1 complex, which is associated with actively transcribing RNA polymerase II[1]. RTF1 is critical for efficient transcription elongation and chromatin remodeling, primarily through its Plus3 domain, which binds to both RNA polymerase II and the DSIF elongation factor SPT5[1]. It stimulates the velocity of RNA polymerase II during gene transcription, and is uniquely required for cotranscriptional histone modifications such as H2B ubiquitination and H3-K4/K79 methylation, linking DNA transcription with chromatin structure modulation[1][2][3][4][5]. RTF1 can in some contexts function independently from the canonical PAF1 complex[1]. While not a current therapeutic target, it is essential for proper gene regulation, and dysfunction may participate in the epigenetic dysregulation found in some diseases[1][2][3].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA polymerase-associated protein RTF1 homolog (RTF1).